Physician profile
Suzanne C Ware
NPI 1265549083
$1,440.85
in general payments reported to CMS, 2019-2025
15 companies · $288 in 2025
The $288 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $391 · 2022: $92.01 · 2023: $257 · 2024: $413 · 2025: $288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $958.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $958.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $260.56 | 2021-2023 | |
| Sanofi-Aventis U.S. LLC | $250.00 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $199.54 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Exact Sciences Corporation | $169.23 | 2023-2024 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $154.43 | 2024-2025 | Trelegy Ellipta |
| Novo Nordisk INC | $152.67 | 2021-2025 | Wegovy, Ozempic |
| Lilly USA, LLC | $67.33 | 2021-2024 | Mounjaro |
| Sumitomo Pharma America, INC. | $45.60 | 2025 | Gemtesa |
| Teva Pharmaceuticals USA, INC. | $25.22 | 2025 | Austedo Xr |
| Amgen INC. | $24.26 | 2025 | Repatha |
| Abbott Laboratories | $24.04 | 2023 | Freestyle Libre 2 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.23 | 2022 | |
| Pfizer INC. | $17.33 | 2024 | |
| Lundbeck LLC | $13.79 | 2024 | Rexulti |
| Medtronic, INC. | $13.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Ware listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.